Finally, the results provide novel insights into the potential biomarkers for KRAS mutant CRC, which may contribute to a better understanding of the molecular and cellular mechanisms mediating the KRAS mutation-induced malignant transformation. This evidence concerns the gene KRAS and colorectal carcinoma.